Maria Skłodowska-Curie Institute of Oncology / Centrum Onkologii–Instytut im. Marii Skłodowskiej-Curie w Warszawie
Research facility
Location:
Warsaw,
Poland (PL)
ISNI: 0000000405402543
ROR: https://ror.org/04qcjsm24
Second allogeneic stem cell transplantation in acute lymphoblastic leukemia patients in second complete remission or relapse: A study on behalf of the ALWP / EBMT (2019)
Nagler A, Labopin M, Finke J, Brecht A, Schanz U, Niittyvuopio R, Neubauer A, et al.
Conference contribution
Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk (2019)
Yang Y, Wu L, Shu X, Lu Y, Shu XO, Cai Q, Beeghly-Fadiel A, et al.
Journal article
Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus (2019)
Buckley MA, Woods NT, Tyrer JP, Mendoza-Fandino G, Lawrenson K, Hazelett DJ, Najafabadi HS, et al.
Journal article
Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation (2019)
Nagler A, Labopin M, Dholaria B, Finke J, Brecht A, Schanz U, Niittyvuopio R, et al.
Journal article
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study (2018)
Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, et al.
Journal article
A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk (2018)
Lu Y, Beeghly-Fadiel A, Wu L, Guo X, Li B, Schildkraut JM, Im HK, et al.
Journal article
QOL After APBI (Multicatheter Brachytherapy) Versus WBI: 5-Year Results, Phase 3 GEC-ESTRO Trial (2018)
Schaefer R, Strnad V, Polgar C, Uter W, Hildebrandt G, Ott OJ, Kauer-Dorner D, et al.
Conference contribution
Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial (2018)
Schaefer R, Strnad V, Polgar C, Uter W, Hildebrandt G, Ott OJ, Kauer-Dorner D, et al.
Journal article
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology (2018)
Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching P, Beckmann M, Ekici AB, et al.
Journal article
Identification of nine new susceptibility loci for endometrial cancer (2018)
O'Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, et al.
Journal article